NCT02949362 - Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 9, 2016

Primary Completion Date

July 14, 2020

Study Completion Date

July 14, 2020

Conditions

Short Bowel Syndrome

Interventions

DRUG

Teduglutide

0.05mg/kg

OTHER

SOC

Standard safety assessments and adjustments in nutritional support will be provided for all subjects throughout the study, including any teduglutide treatment periods

Trial Locations (11)

10467

Children's Hospital at Montefiore, The Bronx

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

46202

Riley Hospital for Children, Indianapolis

53792

University of Wisconsin School of Medicine and Public Health, Madison

64108

Children's Mercy Hospitals and Clinics, Kansas City

77030

Texas Children's Hospital, Houston

90027

Childrens Hospital Los Angeles - RHU, Los Angeles

90095

Mattel Children's Hospital UCLA, Los Angeles

98105

Seattle Children's Hospital, Seattle

02115

Boston Children's Hospital, Boston

WC1N 3JH

Great Ormond Children's Hospital, London